期刊文献+

老年2型糖尿病患者周围神经病变与维生素D的相关性研究 被引量:8

Relationship between peripheral neuropathy and vitamin D in elderly patients with type 2 diabetes
原文传递
导出
摘要 目的探讨老年糖尿病周围神经病变(diabetic peripheral neuropathy,DPN)患者维生素D水平及相关性。方法回顾性病例对照研究,收集2016年6月至2017年9月入住我院内分泌科849例老年2型糖尿病患者临床资料,按照DPN诊断标准分为非DPN组542例和DPN组307例。检查血清25(OH)维生素D[25(OH)vitamin D,25(OH)VD]水平和血生化指标。分析DPN组与非DPN组间各指标差异,并对DPN的危险因素进行Logistic回归分析和绘制受试者工作特征(ROC)曲线。结果849例患者25(OH)VD水平为(43.9±19.4)nmol/L,DPN组患者25(OH)VD水平(40.9±20.4)nmol/L低于非DPN组患者(45.7±18.6)nmol/L(P<0.05),DPN组患者25(OH)VD缺乏率为72.3%(222例),高于非DPN组患者的64.6%(350例)(P<0.05)。二元Logistic回归分析结果显示,DPN独立保护因素为25(OH)VD(OR=0.980,95%CI:0.964~0.995,P<0.05),危险因素为病程(OR=1.048,95%CI:1.027~1.070,P<0.001)。ROC曲线显示发生DPN的25(OH)VD诊断界点值为37.5 nmol/L,约登指数0.17,灵敏度0.65,特异度0.52。结论糖尿病患者维生素D水平偏低,尤以DPN患者为重。较高水平25(OH)VD可能是老年2型糖尿病患者DPN的保护因素,且维生素D可作为预测DPN发生的潜在生物标志物之一。 Objective To investigate the levels of vitamin D and the correlation between DPN and vitamin D in elderly patients with diabetic peripheral neuropathy(DPN).Methods A total of 849 patients aged 60 years and over admitted into endocrinology department from June 2016 to September 2017 were enrolled in this retrospective case-control study.According to DPN diagnostic criteria,patients were divided into the non-DPN group(n=542)and the DPN group(n=307).The 25(OH)-vitamin D[25(OH)D]level and blood biochemical parameters were determined and compared between the two groups.The risk factors for DPN were analyzed using logistic regression analysis and plotting receiver operating characteristic(ROC)curves.Results The mean of serum 25(OH)D level in the 849 patients was 43.9±19.4 nmol/L.Serum 25(OH)D level was lower in the DPN patients than in the non-DPN patients[(40.9±20.4)nmol/L vs.(45.7±18.6)nmol/L,P<0.05].The incidence of 25(OH)D deficiency was higher in the DPN group than in the non-DPN group(72.3%or 222/307 vs.64.6%or 350/542,P<0.05).Binary logistic regression analysis indicated that 25(OH)D was a protective factor for DPN(OR=0.980,95%CI:0.964~0.995,P<0.05)and the disease duration was a risk factor for DPN(OR=1.048,95%CI:1.027~1.070,P<0.001).ROC analysis indicated that the diagnostic cut-off value of serum 25(OH)D for predicting DPN was 37.5nmol/L,with a Youden index of 0.17,sensitivity of 0.65 and specificity of 0.52.Conclusions The 25(OH)D level is much lower in diabetic patients,especially in DPN patients.Higher 25(OH)VD level might be a protective factor for DPN,and vitamin D might be one of potential biomarkers for DPN in diabetic patients.
作者 牛杨 许凯婕 吴江 盛金叶 彭荣霞 李继 汤庆娅 Niu Yang;Xu Kaijie;Wu Jiang;Sheng Jinye;Peng Rongxia;Li Ji;Tang Qingya(Department of Clinical Nutrition,Xinhua Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200092,China)
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2019年第9期1002-1005,共4页 Chinese Journal of Geriatrics
关键词 糖尿病神经病变 糖尿病 2型 维生素D Diabetic neuropathies Diabetes mellitus,type 2 Vitamin D
  • 相关文献

参考文献5

二级参考文献36

  • 1Gerasimos Dimitropoulos,Abd A Tahrani,Martin J Stevens.Cardiac autonomic neuropathy in patients with diabetes mellitus[J].World Journal of Diabetes,2014,5(1):17-39. 被引量:54
  • 2贾伟平,沈琴,包玉倩,陆俊茜,李鸣,项坤三.糖尿病周围神经病变的检测方法及其诊断价值的评估[J].中华医学杂志,2006,86(38):2707-2710. 被引量:88
  • 3汤正义.糖尿病周围神经病变客观检查方法的应用和研究现状[J].内科理论与实践,2007,2(3):157-159. 被引量:12
  • 4中国2型糖尿病防治指南,2007年版.
  • 5American Diabetes Association.Clinical Practice Recommendations.Diabetes Care,2009,31,S12-S54.
  • 6Said G.Diabetic neuropathy--a review.Nat Clin Pract Neurol.2007,3:331-340.
  • 7Sima AA.New insights into the metabolic and molecular basis for diabetic neuropathy.Cell Mol Life Sci,2003,60:1-20.
  • 8Ziegler D,Siekierka KE,Meyer B,et al.Validation of a novel screening device(NeuroQuick) for quantitative assessment of small nerve fiber dysfunction as an early feature of diabetic polyneuropathy.Diabetes Care,2005,28:1169-1174.
  • 9Bouhon AJ,Vinik AI,Arezzo JC,et al.Diabetic neuropathies:a statement by the American Diabetes Association.Diabetes Care,2005,8:956-962.
  • 10Zin CS,Nissen LM,Smith MT,et al.An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy.CNS Drugs,2008,22:417-442.

共引文献7203

同被引文献75

引证文献8

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部